GLP-1 drugs: what NJ FamilyCare paid

NJ FamilyCare shows a published payment figure for 6 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read NJ FamilyCare's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What NJ FamilyCare’s payment record shows

In 2026Q1, the product NJ FamilyCare paid for most often was Ozempic®, at 9,285 prescriptions¹⁹ of the 24,204 to 24,456^{1,7,13,19,25,43} across all 8 products, or 38 percent of the published count.

NJ FamilyCare itself reimbursed at least $22,733,726 for these products in the quarter, about $940 per prescription. Pharmacies were paid $23,272,722 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,328.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what NJ FamilyCare finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, NJ FamilyCare. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What NJ FamilyCare paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what NJ FamilyCare paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Managed care	at least 2,510¹	10%	$2,694,138	$2,696,231	$1,073
tirzepatideMounjaro®	Managed care	at least 6,925⁷	29%	$7,525,467	$7,805,046	$1,087
semaglutideWegovy®	Managed care	at least 919¹³	4%	$1,220,877	$1,222,853	$1,328
semaglutideOzempic®	Both9,268 managed care, 17 direct	at least 9,285¹⁹	38%	$9,392,903	$9,623,889	$1,012
semaglutideRybelsus®	Managed care	at least 381²⁵	2%	$379,024	$401,605	$995
liraglutideSaxenda®	Managed care	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both	Withheld	n/a	Not published	Not published	Not published
liraglutideliraglutide (generic)	Managed care	at least 4,156⁴³	17%	$1,521,318	$1,523,097	$366

NJ FamilyCare publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Against enrollment, that is 16.0 to 16.2 prescriptions per thousand people enrolled in NJ FamilyCare, on an average of 1,510,027 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 33 of the 168 product-quarters it holds a row for here, which is 20 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic® and Rybelsus® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether NJ FamilyCare pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what NJ FamilyCare paid for each product, quarter by quarter

Prescriptions NJ FamilyCare paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable⁴Withheld2 of 2 product codes withheld	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable³Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³Withheld3 of 3 product codes withheld	at least 119 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$126,072 paid	at least 873 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$935,827 paid	at least 2,165 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$2,304,636 paid	at least 3,228 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$3,470,134 paid	at least 2,510 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$2,694,138 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹¹Withheld1 of 1 product codes withheld	at least 39 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$31,117 paid	at least 298 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$222,380 paid	at least 735 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$624,878 paid	at least 1,204 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$1,046,873 paid	at least 1,630 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$1,391,275 paid	at least 1,973 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$1,702,974 paid	at least 3,594 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$3,640,753 paid	at least 4,637 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$4,727,066 paid	at least 5,420 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$5,672,348 paid	at least 6,114 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$6,564,277 paid	at least 6,825 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$7,001,772 paid	at least 9,153 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$9,602,370 paid	at least 10,441 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$11,099,881 paid	at least 11,461 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$12,220,208 paid	at least 6,925 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$7,525,467 paid
semaglutideWegovy®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable¹⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable¹⁸Withheld1 of 1 product codes withheld	at least 12 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld¹⁷At least$6,037 paid	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹⁷Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹⁷Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q4)every reporting cell was withheld, so nothing is observable¹⁷Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable¹⁶Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable¹⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable¹⁶Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter¹⁶No row	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable¹⁵Withheld1 of 1 product codes withheld	at least 25 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld¹⁵At least$26,870 paid	at least 143 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld¹⁵At least$166,254 paid	at least 287 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$364,203 paid	at least 601 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld¹⁴At least$797,264 paid	at least 879 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$1,164,129 paid	at least 1,038 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld¹⁴At least$1,373,477 paid	at least 1,311 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld¹⁴At least$1,736,966 paid	at least 919 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$1,220,877 paid
semaglutideOzempic®range 14,291 to 16,303	at least 2,004 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$1,663,095 paid	at least 2,388 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$1,996,817 paid	at least 2,628 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$2,198,596 paid	at least 2,914 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$2,477,509 paid	at least 3,339 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$2,911,319 paid	at least 4,071 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$3,497,704 paid	at least 4,834 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$4,185,135 paid	at least 5,477 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$4,701,403 paid	at least 7,203 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$6,405,907 paid	at least 8,476 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$7,081,703 paid	at least 9,259 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$7,581,944 paid	at least 8,618 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$7,164,896 paid	at least 11,444 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$10,383,817 paid	at least 13,361 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$12,453,951 paid	14,291 paid prescriptions in the quarter (2024Q3)²¹Count$13,451,231 paid	at least 14,808 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$14,076,882 paid	at least 14,823 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$14,284,298 paid	at least 16,837 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$16,458,863 paid	at least 16,846 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$16,613,913 paid	16,303 paid prescriptions in the quarter (2025Q4)²⁰Count$16,117,008 paid	at least 9,285 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$9,392,903 paid
semaglutideRybelsus®range 239 to 730	at least 171 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$128,195 paid	239 paid prescriptions in the quarter (2021Q2)³⁰Count$172,709 paid	at least 383 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$262,961 paid	at least 417 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$279,466 paid	at least 460 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$308,601 paid	at least 548 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$377,829 paid	at least 637 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$454,101 paid	at least 706 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$495,786 paid	at least 730 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$572,471 paid	at least 799 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$628,788 paid	at least 845 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$631,310 paid	at least 709 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$530,315 paid	at least 720 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$594,153 paid	at least 724 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$663,953 paid	at least 741 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$653,432 paid	at least 690 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$644,327 paid	at least 638 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$625,454 paid	at least 700 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$692,507 paid	730 paid prescriptions in the quarter (2025Q3)²⁶Count$712,443 paid	at least 696 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$676,021 paid	at least 381 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$379,024 paid
liraglutideSaxenda®range 12 to 16	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q2)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	12 paid prescriptions in the quarter (2022Q1)³⁵Count$6,766 paid	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	16 paid prescriptions in the quarter (2022Q3)³⁵Count$6,102 paid	13 paid prescriptions in the quarter (2022Q4)³⁵Count$6,085 paid	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 103 to 6,270	6,136 paid prescriptions in the quarter (2021Q1)⁴²Count$5,372,252 paid	6,270 paid prescriptions in the quarter (2021Q2)⁴²Count$5,546,965 paid	at least 6,473 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld⁴²At least$5,697,394 paid	at least 6,358 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld⁴²At least$5,593,284 paid	at least 6,374 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld⁴¹At least$5,793,766 paid	at least 6,425 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld⁴¹At least$5,876,450 paid	at least 6,705 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld⁴¹At least$6,105,973 paid	at least 6,816 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld⁴¹At least$6,213,094 paid	at least 6,610 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld⁴⁰At least$6,310,028 paid	at least 6,204 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld⁴⁰At least$5,911,397 paid	at least 5,836 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld⁴⁰At least$5,496,802 paid	at least 5,644 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld⁴⁰At least$5,242,030 paid	at least 5,636 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³⁹At least$3,820,879 paid	at least 4,760 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³⁹At least$3,161,170 paid	at least 336 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³⁹At least$189,206 paid	103 paid prescriptions in the quarter (2024Q4)³⁹Count$53,328 paid	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable³⁸Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³⁷Withheld1 of 1 product codes withheld
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	44 paid prescriptions in the quarter (2024Q2)⁴⁵Count$26,564 paid	at least 5,011 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$2,878,993 paid	at least 5,591 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$3,211,254 paid	at least 5,788 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$3,060,339 paid	at least 8,419 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$3,953,257 paid	at least 8,921 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$3,508,195 paid	at least 7,867 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$2,942,637 paid	at least 4,156 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$1,521,318 paid

What this page cannot tell you

Whether NJ FamilyCare covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open New Jersey in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, NJ
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state NJ, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NJ", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "660"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, NJ
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state NJ, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "891"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, NJ
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state NJ, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, NJ
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state NJ, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, NJ
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state NJ, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "product_name": "product_name like ZEPBOUND%, state NJ, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, NJ
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state NJ, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "product_name": "product_name like ZEPBOUND%, state NJ, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, NJ
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state NJ, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NJ", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1610"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, NJ
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state NJ, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "2723"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, NJ
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state NJ, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1633"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, NJ
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state NJ, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "558"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, NJ
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state NJ, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 2", "suppression_used": "false", "number_of_prescriptions": "118"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, NJ
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state NJ, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "product_name": "product_name like MOUNJARO%, state NJ, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, NJ
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state NJ, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NJ", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "218"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, NJ
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state NJ, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "336"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, NJ
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state NJ, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "120"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, NJ
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state NJ, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, NJ
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state NJ, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "12"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, NJ
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state NJ, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, NJ
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state NJ, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NJ", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "3624"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, NJ
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state NJ, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "6487"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, NJ
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state NJ, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "5962"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, NJ
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state NJ, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "3711"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, NJ
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state NJ, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "2546"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, NJ
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state NJ, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1531"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, NJ
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state NJ, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NJ", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "164"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, NJ
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state NJ, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "343"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, NJ
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state NJ, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "383"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, NJ
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state NJ, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "459"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, NJ
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state NJ, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "386"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, NJ
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state NJ, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "232"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, NJ
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state NJ, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NJ", "product_name": "product_name like SAXENDA%, state NJ, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, NJ
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state NJ, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, NJ
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state NJ, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, NJ
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state NJ, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, NJ
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state NJ, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "16"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, NJ
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state NJ, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, NJ
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state NJ, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NJ", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, NJ
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state NJ, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, NJ
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state NJ, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "3445"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, NJ
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state NJ, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "4176"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, NJ
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state NJ, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "4358"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, NJ
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state NJ, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "4363"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, NJ
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state NJ, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NJ", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "986"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, NJ
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state NJ, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "2462"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, NJ
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state NJ, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "3074"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, NJ
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state NJ, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "product_name": "product_name like LIRAGLUTID%, state NJ, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, NJ
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state NJ, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "product_name": "product_name like LIRAGLUTID%, state NJ, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, NJ
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state NJ, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NJ", "product_name": "product_name like LIRAGLUTID%, state NJ, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 41 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 7 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean NJ FamilyCare covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.